Contribute Try STAT+ Today

Editor’s note: A recording of the event is embedded below. 

In 2020, biotech changed forever. So what will happen in 2021? We’ll look back at how the biotech industry confronted the pandemic and ahead to what could happen in 2021 as the world slowly returns to normal. And just because the J.P. Morgan Healthcare Conference is virtual this year doesn’t mean it won’t be an epicenter of conversations, announcements, and deals. STAT’s biotech team will take the virtual stage to forecast the year to come. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.